{"id":"https://genegraph.clinicalgenome.org/r/b42fc816-b3ba-4597-80f0-4340ca644aadv1.0","type":"EvidenceStrengthAssertion","dc:description":"*SGPL1* was first reported in relation to autosomal recessive nephrotic syndrome 14 in 2017 (Prasad et al., PMID: 28165343 and Lovric et al., PMID: 28165339). This condition can include steroid-resistant nephrotic syndrome, primary adrenal insufficiency, testicular insufficiency, hypothyroidism, ichthyosis, lymphopenia, immunodeficiency, developmental delay, and peripheral motor and sensory neuropathy. Prenatal features of this condition may include fetal hydrops, increased nuchal translucency, skin edema, polyhydramnios, and adrenal calcifications. Fifteen variants (missense, frameshift, nonsense, canonical splice site) that have been reported in 12 probands in five publications (PMIDs: 28165343, 28165339, 28181337, 29501407, 32855188, 32855188) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity is reported to be loss of function. This gene-disease relationship is also supported by animal models (PMIDs: 19119317, 28165343, 28165339). Null mouse models recapitulate the human renal and adrenal phenotype and knock-in of human S1PL in the heterozygous or homozygous state partially rescued enzyme activity. In summary, there is definitive evidence supporting the relationship between *SGPL1* and autosomal recessive nephrotic syndrome 14. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Prenatal GCEP on September 18, 2024 (SOP Version 11). ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/b42fc816-b3ba-4597-80f0-4340ca644aad","GCISnapshot":"https://genegraph.clinicalgenome.org/r/ba9aea8b-0361-46c5-af9d-e45eba0723d7","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/ba9aea8b-0361-46c5-af9d-e45eba0723d7_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10106","date":"2024-09-18T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/ba9aea8b-0361-46c5-af9d-e45eba0723d7_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10106","date":"2025-03-05T21:54:38.696Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba9aea8b-0361-46c5-af9d-e45eba0723d7_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3117900-24f9-4cd6-b6ba-3bb31b893ca0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b84d60f5-126f-4f92-879f-ce8d79946263","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b84d60f5-126f-4f92-879f-ce8d79946263_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855188","allele":{"id":"https://genegraph.clinicalgenome.org/r/9c4807e9-cb32-46af-853a-74f43e522281","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.868T>C (p.Phe290Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377123424"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/3c3a65e3-89bc-4696-a9f5-c0bc2de477fe","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c3a65e3-89bc-4696-a9f5-c0bc2de477fe_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855188","allele":{"id":"https://genegraph.clinicalgenome.org/r/d3172d10-8a49-4705-b6f5-68fcf7568940","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.993C>G (p.Tyr331Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377123707"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/e3117900-24f9-4cd6-b6ba-3bb31b893ca0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/32855188","rdfs:label":"Martin 2020: Patient 3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/d3172d10-8a49-4705-b6f5-68fcf7568940"},{"id":"https://genegraph.clinicalgenome.org/r/9c4807e9-cb32-46af-853a-74f43e522281"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Adrenal calcifications and polyhydramnios on prenatal US (fetal MRI showed enlarged and echogenic adrenals), perinatal apnea, bilateral hearing loss, immunodeficiency, nephrotic syndrome with massive kidney enlargement requiring bilateral nephrectomy and peritoneal dialysis at 3 months of age, adrenal\ninsufficiency and esotropia diagnosed at 1 year, developmental regression beginning at 13 months, seizures, deceased at 17 months.","phenotypes":["obo:HP_0001561","obo:HP_0001250","obo:HP_0000565","obo:HP_0002104","obo:HP_0002376","obo:HP_0010512","obo:HP_0000100","obo:HP_0002721","obo:HP_0000846","obo:HP_0000365"],"previousTesting":false,"sex":"UnknownEthnicity","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b84d60f5-126f-4f92-879f-ce8d79946263_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/3c3a65e3-89bc-4696-a9f5-c0bc2de477fe_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.6},{"id":"https://genegraph.clinicalgenome.org/r/3c008e78-5fb8-4ef0-be3f-f828799a9651_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe39ba25-bdc6-4075-8c1c-3df664708c96","type":"EvidenceLine","dc:description":"Deducted points for consanguinity","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fe39ba25-bdc6-4075-8c1c-3df664708c96_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29501407","allele":{"id":"https://genegraph.clinicalgenome.org/r/360fe1bc-d245-41f3-a047-ae5d0ca2e3bb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.1233del (p.Phe411LeufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695212151"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/3c008e78-5fb8-4ef0-be3f-f828799a9651","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29501407","rdfs:label":"Bamborschke 2018: Proband","ageType":"AgeAtOnset","ageUnit":"WeeksGestation","ageValue":30,"allele":{"id":"https://genegraph.clinicalgenome.org/r/360fe1bc-d245-41f3-a047-ae5d0ca2e3bb"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Severe fetal hydrops noted at 30w GA, after birth had massive pleural effusions and ascites, congenital nephrotic syndrome, adrenal calcifications, microcephaly, generalized cortical atrophy, hypoplastic temporal lobes, cerebellar hypoplasia, dysmorphic facies (hypertelorism, down slanting palpebral fissures), no testes palpated, deceased at 6 weeks of life.","previousTesting":false,"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/fe39ba25-bdc6-4075-8c1c-3df664708c96_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/cc0dc7a8-25b6-4013-8d0b-84205f574be0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/254e0f20-2168-4166-8f24-1390e5b71e46","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/254e0f20-2168-4166-8f24-1390e5b71e46_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vivo yeast complementation assay with deletion of SGPL1 yeast ortholog showed variant was unable to improve growth.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/254e0f20-2168-4166-8f24-1390e5b71e46_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","allele":{"id":"https://genegraph.clinicalgenome.org/r/a52e7e53-5539-44d6-9cda-cca960fad8b3","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.7dup (p.Ser3LysfsTer11)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645372500"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/cc0dc7a8-25b6-4013-8d0b-84205f574be0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","rdfs:label":"Lovric 2017: A280_22","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":10,"allele":{"id":"https://genegraph.clinicalgenome.org/r/a52e7e53-5539-44d6-9cda-cca960fad8b3"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"steroid-resistant nephrotic syndrome at 10 months (transplants at 5y and 12y; relapse with massive proteinuria at 15y), focal segmental glomerulosclerosis at 1y, scaly skin lesions, hyperchromic skin ichthyosis vulgaris, glucocorticoid deficiency, acrosomia, asymmetric skull, moderate scoliosis.","phenotypes":["obo:HP_0008064","obo:HP_0000097","obo:HP_0012588","obo:HP_0002650","obo:HP_0012111"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/254e0f20-2168-4166-8f24-1390e5b71e46_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/74f2fdc8-fdf0-4390-99b4-d78d5efebdd0_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e3830bf-abe0-468c-95b4-50137d77e90a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2e3830bf-abe0-468c-95b4-50137d77e90a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant is predicted to result in exon 5 skipping, fibroblasts from patient showed almost no protein at predicted size (Western blot), PCR confirmed exon skipping leading to a frameshift (p.Ile88Thrfs*25).","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/2e3830bf-abe0-468c-95b4-50137d77e90a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","allele":{"id":"https://genegraph.clinicalgenome.org/r/f9a06344-d572-4c29-b2f4-c3fdc32e07e8","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.395A>G (p.Glu132Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377118196"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9bddee23-80fd-44c3-8091-a99a356759fb","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bddee23-80fd-44c3-8091-a99a356759fb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Variant had significantly reduced lyase activity in HEK293T cells; enzyme activity in patient dermal fibroblasts showed reduced activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9bddee23-80fd-44c3-8091-a99a356759fb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","allele":{"id":"https://genegraph.clinicalgenome.org/r/27d14b4d-86c7-4251-92dc-c778e0066ac7","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.832del (p.Arg278GlyfsTer17)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2695212150"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/74f2fdc8-fdf0-4390-99b4-d78d5efebdd0","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","rdfs:label":"Lovri 2017: NCR61_1","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":2,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/27d14b4d-86c7-4251-92dc-c778e0066ac7"},{"id":"https://genegraph.clinicalgenome.org/r/f9a06344-d572-4c29-b2f4-c3fdc32e07e8"}],"firstTestingMethod":"Exome sequencing","phenotypeFreeText":", SRNS at 2y, ESRD at 6y, FSGS, ichthyosis, adrenal insufficiency at 2y; affected sib","phenotypes":["obo:HP_0000097","obo:HP_0003774","obo:HP_0012588","obo:HP_0008064","obo:HP_0000846"],"previousTesting":false,"sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/2e3830bf-abe0-468c-95b4-50137d77e90a_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9bddee23-80fd-44c3-8091-a99a356759fb_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/efb1c1de-b142-4378-ab4d-1649ad564999_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bc1a9e9-f825-4038-9511-8eff1c9ff989","type":"EvidenceLine","dc:description":"Deducted 0.5 points from case due to consanguinity","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2bc1a9e9-f825-4038-9511-8eff1c9ff989_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28181337","allele":{"id":"https://genegraph.clinicalgenome.org/r/6a56154a-975b-4350-bf39-2d9fbf2f3e41","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.934del (p.Leu312PhefsTer30)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA645372501"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/efb1c1de-b142-4378-ab4d-1649ad564999","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28181337","rdfs:label":"Janecke 2017: Patient 3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/6a56154a-975b-4350-bf39-2d9fbf2f3e41"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Unilateral hydrothorax and generalized skin edema at 12wGA (not seen at 16w), CNS, adrenal insufficiency, adrenal calcifications, micropenis, cryptorchidism, hypergonadotropic hypogonadism.","phenotypes":["obo:HP_0000815","obo:HP_0025672","obo:HP_0010512","obo:HP_0000028","obo:HP_0000846","obo:HP_0000054","obo:HP_0000100","obo:HP_0025678"],"previousTesting":true,"previousTestingDescription":"Normal karyotype (46,XY), negative LIPA and WT sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/2bc1a9e9-f825-4038-9511-8eff1c9ff989_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5},{"id":"https://genegraph.clinicalgenome.org/r/803f1eeb-4ae3-400a-8e2f-8696c3d868cd_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82a2c6e7-eb27-448d-b061-d6b56b6f56b1","type":"EvidenceLine","dc:description":"Deducted 0.5 points for consanguinity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/82a2c6e7-eb27-448d-b061-d6b56b6f56b1_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expressed in HEK293T cells  - reduced expression, no dimer formation observed, when overexpressed with WT there was abnormal cytoplasmic aggregates; Lyase activity significantly reduced in HEK293T cells; enzyme activity in patient dermal fibroblasts: reduced activity; In vivo yeast complementation assay with deletion of SGPL1 yeast ortholog showed variant was unable to rescue growth.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/82a2c6e7-eb27-448d-b061-d6b56b6f56b1_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","allele":{"id":"https://genegraph.clinicalgenome.org/r/bfb9a182-5432-4d18-b44c-2792a2daea99","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.664C>T (p.Arg222Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377121889"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/803f1eeb-4ae3-400a-8e2f-8696c3d868cd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","rdfs:label":"Lovric 2017: EB_2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/bfb9a182-5432-4d18-b44c-2792a2daea99"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Female with fetal hydrops, congenital nephrotic syndrome, died at 2 months.\n","phenotypes":["obo:HP_0001790","obo:HP_0000100"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/82a2c6e7-eb27-448d-b061-d6b56b6f56b1_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/783c1c93-e9ef-45ed-aa7b-c70580a90924_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/710610aa-8b23-49b9-a264-48e441d732c2","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/710610aa-8b23-49b9-a264-48e441d732c2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","allele":{"id":"https://genegraph.clinicalgenome.org/r/bd8a239c-3c21-4336-92d2-5e413de2ddf9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.946G>A (p.Ala316Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377123603"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/8ebf2462-f04c-465c-bf93-33f51a07a17d","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8ebf2462-f04c-465c-bf93-33f51a07a17d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","allele":{"id":"https://genegraph.clinicalgenome.org/r/04fe7978-da09-4ea9-b415-7f293e1b2c17","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.605C>T (p.Ser202Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA209387723"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/783c1c93-e9ef-45ed-aa7b-c70580a90924","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","rdfs:label":"Lovric 2017: MC","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":18,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/bd8a239c-3c21-4336-92d2-5e413de2ddf9"},{"id":"https://genegraph.clinicalgenome.org/r/04fe7978-da09-4ea9-b415-7f293e1b2c17"}],"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0000486","obo:HP_0004313","obo:HP_0009830","obo:HP_0000646","obo:HP_0001873","obo:HP_0000097","obo:HP_0001888"],"previousTesting":false,"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/710610aa-8b23-49b9-a264-48e441d732c2_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/8ebf2462-f04c-465c-bf93-33f51a07a17d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.2},{"id":"https://genegraph.clinicalgenome.org/r/0e921a92-aac4-4636-be9a-a5e31eabc9c2_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/123d28da-d480-467f-b9a2-46290d996d52","type":"EvidenceLine","dc:description":"Deducted points for consanguinity","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/123d28da-d480-467f-b9a2-46290d996d52_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"S1P levels in patient blood was elevated compared to 2 healthy controls (SGPL1 is responsible for catalyzing the degradation of S1P), levels of SPH (precursor to S1P) were also elevated. In cultured skin fibroblasts, S1P and SPH were also shown to be elevated in the patient compared to controls.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/123d28da-d480-467f-b9a2-46290d996d52_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28181337","allele":{"id":"https://genegraph.clinicalgenome.org/r/c1eb97a8-8c6c-4541-96e8-9927871b358f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.1513C>T (p.Arg505Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA209397949"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.5},{"id":"https://genegraph.clinicalgenome.org/r/0e921a92-aac4-4636-be9a-a5e31eabc9c2","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28181337","rdfs:label":"Janecke 2017: Patient 2","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/c1eb97a8-8c6c-4541-96e8-9927871b358f"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":", Abnormal NT measurement, elevated risk for T21 on maternal serum screening, FSGS, proteinuria, small penis, no palpable testes, bilateral adrenal calcifications at 21w gestation, died suddenly at 3 months of life.","phenotypes":["obo:HP_0000097","obo:HP_0000093","obo:HP_0000054","obo:HP_0010512","obo:HP_0010880"],"previousTesting":true,"previousTestingDescription":"Negative chromosome microarray, normal karyotype, negative Smith-Lemli-Opitz testing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/123d28da-d480-467f-b9a2-46290d996d52_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/95960e89-e925-4b13-baaf-6048bb2c0abb_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bfe86e7-bf1e-456a-ad40-2002d57d135c","type":"EvidenceLine","dc:description":"Deducted 0.5 points for consanguinity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bfe86e7-bf1e-456a-ad40-2002d57d135c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"In vivo yeast complementation assay with deletion of SGPL1 yeast ortholog showed variant was unable to rescue growth.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4bfe86e7-bf1e-456a-ad40-2002d57d135c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","allele":{"id":"https://genegraph.clinicalgenome.org/r/67dc13bd-8876-4578-83d0-3ea977c785d1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.1247A>G (p.Tyr416Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5541409"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/95960e89-e925-4b13-baaf-6048bb2c0abb","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","rdfs:label":"Lovric 2017: B1245_21","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/67dc13bd-8876-4578-83d0-3ea977c785d1"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Congenital nephrotic syndrome, ESRD, peritoneal dialysis, FSGS, AI, bilateral SNHL, lymphopenia, FTT, DD, hypothyroidism, mild dilated cardiomyopathy.","phenotypes":["obo:HP_0000407","obo:HP_0001508","obo:HP_0001888","obo:HP_0000100","obo:HP_0000846","obo:HP_0001644","obo:HP_0000821","obo:HP_0000097","obo:HP_0012758"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4bfe86e7-bf1e-456a-ad40-2002d57d135c_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/c78a50c5-dad9-4adb-b36c-76639caa9cbe_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78b18041-ee9f-4cd5-86c4-7f562ae3d43f","type":"EvidenceLine","dc:description":"Scored each variant as other variant with functional evidence, deducted 0.5 points for consanguinity and added 0.5 points for recurrent variant (also seen in another family in same publication).","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/78b18041-ee9f-4cd5-86c4-7f562ae3d43f_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Enzyme activity close to zero when mutant protein was expressed in Sgpl1–/– mouse fibroblasts; immunoblotting showed lower amounts compared to wildtype.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/78b18041-ee9f-4cd5-86c4-7f562ae3d43f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165343","allele":{"id":"https://genegraph.clinicalgenome.org/r/59dcdfea-ed2a-4c98-b6b1-702c3a7e643e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.665G>A (p.Arg222Gln)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA5541257"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/c78a50c5-dad9-4adb-b36c-76639caa9cbe","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165343","rdfs:label":"Prasad 2017: Patient 2","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":8,"allele":{"id":"https://genegraph.clinicalgenome.org/r/59dcdfea-ed2a-4c98-b6b1-702c3a7e643e"},"detectionMethod":"WES was performed for family and some affected individuals then had Sanger sequencing","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypeFreeText":"Individual has isolated glucocorticoid deficiency noted at 8m, genital hyperpigmentation, steroid-resistant nephrotic syndrome, biopsy suggestive of FSGS (2.5y), kidney transplant at 5y. Younger sibling with similar history deceased at 4y (not tested). Consanguineous family.","phenotypes":["obo:HP_0012111","obo:HP_0000097","obo:HP_0030258","obo:HP_0012588"],"previousTesting":false,"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/78b18041-ee9f-4cd5-86c4-7f562ae3d43f_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/4999789d-71cd-424b-aca0-a70e6f278a55_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41afca17-b68d-40de-bd3b-3934843d27cb","type":"EvidenceLine","dc:description":"Deducted 0.5 points due to consanguinity","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/41afca17-b68d-40de-bd3b-3934843d27cb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Expressed in HEK293T cells  - reduced expression, no dimer formation observed, when overexpressed with WT there was abnormal cytoplasmic aggregates; Lyase activity significantly reduced in HEK293T cells; enzyme activity in patient dermal fibroblasts: reduced activity; In vivo yeast complementation assay with deletion of SGPL1 yeast ortholog showed variant was unable to rescue growth.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/41afca17-b68d-40de-bd3b-3934843d27cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","allele":{"id":"https://genegraph.clinicalgenome.org/r/49f3703a-e850-490c-902d-71344b6df1cb","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.1037G>T (p.Ser346Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA377123885"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4999789d-71cd-424b-aca0-a70e6f278a55","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","rdfs:label":"Lovric 2017: B56_(12M15411)","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":0,"allele":{"id":"https://genegraph.clinicalgenome.org/r/49f3703a-e850-490c-902d-71344b6df1cb"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001252","obo:HP_0008064","obo:HP_0001888","obo:HP_0000365","obo:HP_0001790","obo:HP_0012758","obo:HP_0000100","obo:HP_0000252"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/41afca17-b68d-40de-bd3b-3934843d27cb_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/0f66019d-c8c6-45e6-9950-beb70a0e558f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bef610bb-9402-47b7-a270-a0889ed3f377","type":"EvidenceLine","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bef610bb-9402-47b7-a270-a0889ed3f377_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Enzyme activity close to zero when mutant protein was expressed in Sgpl1–/– mouse fibroblasts; immunoblotting showed lower amounts compared to wildtype.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bef610bb-9402-47b7-a270-a0889ed3f377_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165343","allele":{"id":"https://genegraph.clinicalgenome.org/r/82ca3142-de18-4258-9231-4b3d04081b59","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_003901.4(SGPL1):c.1635_1637del (p.Phe545del)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA594285575"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.0},{"id":"https://genegraph.clinicalgenome.org/r/0f66019d-c8c6-45e6-9950-beb70a0e558f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165343","rdfs:label":"Prasad 2017: Patient 5","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":6,"allele":{"id":"https://genegraph.clinicalgenome.org/r/82ca3142-de18-4258-9231-4b3d04081b59"},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0008064","obo:HP_0000407","obo:HP_0001251","obo:HP_0002013","obo:HP_0000853","obo:HP_0012758","obo:HP_0008207","obo:HP_0012588","obo:HP_0001508"],"previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/bef610bb-9402-47b7-a270-a0889ed3f377_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/ba9aea8b-0361-46c5-af9d-e45eba0723d7_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ba9aea8b-0361-46c5-af9d-e45eba0723d7_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a5017087-74e8-4ec6-87eb-1d40856a44ef","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3c8aecc1-43bf-45db-80d5-2de46b8a1651","type":"Finding","dc:description":"Null mouse phenotype recapitulates the human phenotype studied.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165343","rdfs:label":"Mouse Model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/49a16679-c907-4141-82a8-ad37996b3805","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/910d9d54-847c-423c-be3b-cd73aca1c363","type":"Finding","dc:description":"Hemizygous flies have similar defects to the podocyte disease identified in humans with SGPL1 variants.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28165339","rdfs:label":"Drosophila studies","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/de7d81f8-3129-41de-b79b-35c038a95371","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/897a7ce6-27fc-407c-a82e-0dfaf368cfe4","type":"Finding","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19119317","rdfs:label":"Rescue in Mouse Model","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityNonHumanRescueCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":4}],"evidenceStrength":"Definitive","sequence":10051,"specifiedBy":"GeneValidityCriteria11","strengthScore":16,"subject":{"id":"https://genegraph.clinicalgenome.org/r/AWIbAHkEHDs","type":"GeneValidityProposition","disease":"obo:MONDO_0033203","gene":"hgnc:10817","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_ba9aea8b-0361-46c5-af9d-e45eba0723d7-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}